Search Results

There are 2144 results for: content related to: Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial

  1. Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2542–2549, Robert A. Hauser, Anthony H.V. Schapira, Olivier Rascol, Paolo Barone, Yoshikuni Mizuno, Laurence Salin, Monika Haaksma, Nolwenn Juhel and Werner Poewe

    Article first published online : 10 NOV 2010, DOI: 10.1002/mds.23317

  2. Pramipexole in the treatment of advanced Parkinson’s disease

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 21–25, J. C. Möller and W. H. Oertel

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1021.x

  3. Pre-clinical studies of pramipexole: clinical relevance

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 15–20, J. P. Hubble

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1015.x

  4. You have free access to this content
    Pramipexole protects against MPTP toxicity in non-human primates

    Journal of Neurochemistry

    Volume 96, Issue 5, March 2006, Pages: 1315–1321, Mahmoud M. Iravani, Claire O. Haddon, J. Mark Cooper, Peter Jenner and Anthony H. Schapira

    Article first published online : 8 FEB 2006, DOI: 10.1111/j.1471-4159.2005.03625.x

  5. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  6. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Article first published online : 27 JAN 2010, DOI: 10.1002/mds.22960

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Article first published online : 12 JUN 2015, DOI: 10.1002/mds.26295

  8. Pramipexole in the treatment of restless legs syndrome: a follow-up study

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 27–31, J. Montplaisir, R. Denesle and D. Petit

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1027.x

  9. Pramipexole-induced somnolence and episodes of daytime sleep

    Movement Disorders

    Volume 15, Issue 4, July 2000, Pages: 658–663, Robert A. Hauser, Lisa Gauger, W. McDowell Anderson and Theresa A. Zesiewicz

    Article first published online : 31 JAN 2001, DOI: 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N

  10. Abnormal behaviours during pramipexole treatment for Cotard's syndrome: a case report

    Psychogeriatrics

    Joji Maruo, Yoshinori Haraguchi, Hiroshi Tateishi, Tomoyuki Noguchi, Yoshito Mizoguchi, Takahiro A. Kato, Toshiro Kawashima and Akira Monji

    Article first published online : 29 SEP 2015, DOI: 10.1111/psyg.12148

  11. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome

    Movement Disorders

    Volume 27, Issue 6, May 2012, Pages: 775–778, Roger Kurlan, Giovanna Crespi, Barbara Coffey, Kirsten Mueller-Vahl, Stephen Koval, Glen Wunderlich and on behalf of the Pramipexole for TS Trial Investigators

    Article first published online : 7 MAR 2012, DOI: 10.1002/mds.24919

  12. You have free access to this content
    Pramipexole-Induced Reversible Heart Failure

    Movement Disorders Clinical Practice

    Volume 1, Issue 4, December 2014, Pages: 381–382, Matveï Apraxine, Agnes Pasquet and Anne Jeanjean

    Article first published online : 23 OCT 2014, DOI: 10.1002/mdc3.12096

  13. You have free access to this content
    Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 5–15, J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli and W. H. Oertel

    Article first published online : 22 DEC 2012, DOI: 10.1111/j.1468-1331.2012.03866.x

  14. Parkinson's disease treatment may cause impulse–control disorder via dopamine D3 receptors

    Synapse

    Volume 69, Issue 4, April 2015, Pages: 183–189, Philip Seeman

    Article first published online : 3 FEB 2015, DOI: 10.1002/syn.21805

  15. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series

    European Journal of Neurology

    Volume 20, Issue 9, September 2013, Pages: 1241–1246, M. Dostal, C. Weber-Schoendorfer, J. Sobesky and C. Schaefer

    Article first published online : 22 OCT 2012, DOI: 10.1111/ene.12001

  16. Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 8, August 2011, Pages: 1177–1185, Dr Michael E. Bozik, Mr James L. Mather, Dr William G. Kramer, Dr Valentin K. Gribkoff and Dr Evan W. Ingersoll

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010379412

  17. Pramipexole in treatment-resistant depression: An extended follow-up

    Depression and Anxiety

    Volume 20, Issue 3, 2004, Pages: 131–138, Paolo Cassano, Lorenzo Lattanzi, Federico Soldani, Serena Navari, Giulia Battistini, Alfredo Gemignani and Giovanni Battista Cassano

    Article first published online : 17 NOV 2004, DOI: 10.1002/da.20038

  18. You have free access to this content
    Pramipexole Reduces Reactive Oxygen Species Production In Vivo and In Vitro and Inhibits the Mitochondrial Permeability Transition Produced by the Parkinsonian Neurotoxin Methylpyridinium Ion

    Journal of Neurochemistry

    Volume 71, Issue 1, July 1998, Pages: 295–301, David S. Cassarino, Christopher P. Fall, Trisha S. Smith and James P. Bennett Jr.

    Article first published online : 13 NOV 2002, DOI: 10.1046/j.1471-4159.1998.71010295.x

  19. Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 1–2, Justo Garcia de Yebenes

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1001.x

  20. You have free access to this content
    Dopamine agonist-responsive depression

    Psychogeriatrics

    Volume 13, Issue 3, September 2013, Pages: 189–195, Hiroaki Hori and Hiroshi Kunugi

    Article first published online : 17 SEP 2013, DOI: 10.1111/psyg.12014